StimLabs
StimLabs, LLC, was founded in 2015 with a desire to advance the state of regenerative medicine. Within a year of its inception, StimLabs built and certified an ISO Class 7 clean room facility, conceptualized and launched a suite of placental-derived products, developed an extensive product pipeline across a range of clinical applications, and established a portfolio of intellectual property. Stimlabs' product portfolio applies to a wide range of clinical applications and provides a foundation on which StimLabs is developing new regenerative technologies at the intersection of pharmaceuticals, medical devices, and tissue transplants.
Last updated on